Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Frontiers in Oncology|December 6, 2021
Tyrosine-Dependent Phenotype Switching Occurs Early in Many Primary Melanoma Cultures Limiting Their Translational ValueAhmad Najem, Jasper Wouters, Mohammad Krayem, et al.Cancers|December 23, 2023
Correction: Krayem et al. The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma. <i>Cancers</i> 2019, <i>11</i>, 1093Mohammad Krayem, Malak Sabbah, Ahmad Najem, et al.Cancers|August 4, 2019
The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in MelanomaMohammad Krayem, Malak Sabbah, Ahmad Najem, et al.European Journal of Medicinal Chemistry|July 1, 2018
Targeting prohibitin with small molecules to promote melanogenesis and apoptosis in melanoma cellsAmel Djehal, Mohammad Krayem, Ahmad Najem, et al.Cells|November 26, 2022
Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug ResistancePashalina Kehagias, Nadège Kindt, Mohammad Krayem, et al.Cancers|May 16, 2023
Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATEWendy Delbart, Gwennaëlle Marin, Basile Stamatopoulos, et al.The Journal of Investigative Dermatology|February 16, 2007
Chromosomal translocations as a mechanism of BRAF activation in two cases of large congenital melanocytic neviBarbara Dessars, Linda E De Raeve, Hakim El Housni, et al.European Journal of Medicinal Chemistry|August 21, 2022
Development of fluorizoline analogues as prohibitin ligands that modulate C-RAF signaling, p21 expression and melanogenesisNora Chouha, Hussein Abou-Hamdan, Hajime Yurugi, et al.The Journal of Investigative Dermatology|July 18, 2008
Genotypic and gene expression studies in congenital melanocytic nevi: insight into initial steps of melanotumorigenesisBarbara Dessars, Linda E De Raeve, Renato Morandini, et al.Cancers|February 27, 2020
Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of ResistanceMohamad Krayem, Philippe Aftimos, Ahmad Najem, et al.Pageof 4